Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors

Medicine and Dentistry

• Solitary Fibrous Tumor 72%
• Mechanistic Target of Rapamycin 45%
• Platelet Derived Growth Factor Receptor 45%
• Protein Tyrosine Kinase 45%
• Combination Therapy 27%
• Somatomedin C Receptor 27%
• Phosphorylation 18%
• Sphingolipid Activator Protein 2 18%
• Patient 9%
• Neoplasm 9%
• Inpatient 9%
• Prognosis 9%
• Malignant Neoplasm 9%
• Cancer 9%
• Carcinogenesis 9%
• Necrosis 9%
• Immunohistochemistry 9%
• Protein 9%
• Overall Survival 9%
• Degeneration 9%
• Ribosome Protein 9%
• Molecularly Targeted Therapy 9%
• Soft Tissue Tumor 9%
• Disease Free Survival 9%
• Hypoglycemia 9%
• Protein S6 9%
• Phosphoprotein 9%

Biochemistry, Genetics and Molecular Biology

• Mammalian Target of Rapamycin 100%
• Staining 81%
• Platelet-Derived Growth Factor Receptor 45%
• Receptor Tyrosine Kinase 36%
• Insulin-Like Growth Factor 1 Receptor 27%
• Sample 18%
• Protein 18%
• Phosphorylation 18%
• Western Blot 18%
• Ribosomal Protein S6 18%
• Binding Protein 9%
• Molecular Biology 9%
• Phosphorylated Protein 9%
• Overall Survival 9%
• Disease Free Survival 9%